-
1
-
-
84884999605
-
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
-
Brown PD, Pugh S, Laack NN, et al (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol, 15, 1429-37.
-
(2013)
Neuro Oncol
, vol.15
, pp. 1429-1437
-
-
Brown, P.D.1
Pugh, S.2
Laack, N.N.3
-
2
-
-
34548862576
-
Combination treatment with ionising radiation and gefitinib (Iressa, ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo
-
Colquhoun AJ, Mchugh LA, Tulchinsky E, et al (2007). Combination treatment with ionising radiation and gefitinib (Iressa, ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. J Radiat Res, 48, 351-360.
-
(2007)
J Radiat Res
, vol.48
, pp. 351-360
-
-
Colquhoun, A.J.1
Mchugh, L.A.2
Tulchinsky, E.3
-
3
-
-
84886571517
-
Should erlotinib be coadministered with whole-brain radiotherapy in patients with brain metastases and non-small-cell lung cancer?
-
Chamberlain MC (2013). Should erlotinib be coadministered with whole-brain radiotherapy in patients with brain metastases and non-small-cell lung cancer? J Clin Oncol, 31, 3164-5.
-
(2013)
J Clin Oncol
, vol.31
, pp. 3164-3165
-
-
Chamberlain, M.C.1
-
4
-
-
84890520102
-
A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone
-
Epub ahead of print
-
Dziggel L, Segedin B, Podvrsnik NH, et al (2013). A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone. Strahlenther Onkol, Epub ahead of print.
-
(2013)
Strahlenther Onkol
-
-
Dziggel, L.1
Segedin, B.2
Podvrsnik, N.H.3
-
5
-
-
84856235127
-
Outcome, Quality of life and congnitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomized phase II trial of the Swiss Group fro Clinical Cancer Research (SAKK 70/03)
-
Gianfranco A, Pesce, Dirk Klingbiel, et al (2012). Outcome, Quality of life and congnitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomized phase II trial of the Swiss Group fro Clinical Cancer Research (SAKK 70/03). Eur J Cancer, 48, 377-384.
-
(2012)
Eur J Cancer
, vol.48
, pp. 377-384
-
-
Gianfranco, A.1
Pesce2
Klingbiel, D.3
-
6
-
-
84888063857
-
Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy
-
Epub ahead of print
-
Harth S, Abo-Madyan Y, Zheng L, et al (2013). Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol, Epub ahead of print.
-
(2013)
Radiother Oncol
-
-
Harth, S.1
Abo-Madyan, Y.2
Zheng, L.3
-
7
-
-
84883465602
-
Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study
-
Hassler MR, Pfeifer W, Knocke-Abulesz TH, et al (2013). Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study. Wien Klin Wochenschr, 125, 481-6.
-
(2013)
Wien Klin Wochenschr
, vol.125
, pp. 481-486
-
-
Hassler, M.R.1
Pfeifer, W.2
Knocke-Abulesz, T.H.3
-
8
-
-
84882369765
-
Concurrent whole brain radiotherapy and bortezomib for brain metastasis
-
Lao CD, Friedman J, Tsien CI, et al (2013). Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol, 8, 204.
-
(2013)
Radiat Oncol
, vol.8
, pp. 204
-
-
Lao, C.D.1
Friedman, J.2
Tsien, C.I.3
-
9
-
-
84864865020
-
Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients
-
Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 301-304
-
-
Li, C.G.1
Huang, X.E.2
Xu, L.3
-
10
-
-
84880282227
-
Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer
-
Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 2663-2665
-
-
Liu, Y.C.1
Zhou, S.B.2
Gao, F.3
-
11
-
-
33744729984
-
The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines
-
Miyata H, Sasaki T, Kuwahara K, et al (2006). The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines. Int J Oncol, 28, 915-921.
-
(2006)
Int J Oncol
, vol.28
, pp. 915-921
-
-
Miyata, H.1
Sasaki, T.2
Kuwahara, K.3
-
12
-
-
84891609260
-
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
-
Epub ahead of print
-
Morris PG, Correa DD, Yahalom J, et al (2013). Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol, Epub ahead of print.
-
(2013)
J Clin Oncol
-
-
Morris, P.G.1
Correa, D.D.2
Yahalom, J.3
-
13
-
-
84885752397
-
Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with Paclitaxel, gemcitabine and Etoposide
-
Natukula K, Jamil K, Pingali UR, et al (2013). Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with Paclitaxel, gemcitabine and Etoposide. Asian Pac J Cancer Prev, 14, 4661-6.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 4661-4666
-
-
Natukula, K.1
Jamil, K.2
Pingali, U.R.3
-
14
-
-
84890805332
-
Treatment of Brain Metastases in Lung Cancer: Strategies to Avoid/Reduce Late Complications of Whole Brain Radiation Therapy
-
Epub ahead of print
-
Shaw MG, Ball DL (2013). Treatment of Brain Metastases in Lung Cancer: Strategies to Avoid/Reduce Late Complications of Whole Brain Radiation Therapy. Curr Treat Options Oncol, Epub ahead of print.
-
(2013)
Curr Treat Options Oncol
-
-
Shaw, M.G.1
Ball, D.L.2
-
15
-
-
67449122414
-
Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population
-
Shenglin Ma, Yaping Xu, Qinghua Deng, et al (2009). Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population. Lung Cancer, 65, 198-203.
-
(2009)
Lung Cancer
, vol.65
, pp. 198-203
-
-
Shenglin, M.A.1
Yaping, X.U.2
Deng, Q.3
-
16
-
-
84884351071
-
What place for the whole brain radiotherapy with hippocampal-sparing
-
Truc G, Martin E, Mirjolet C, et al (2013). What place for the whole brain radiotherapy with hippocampal-sparing. Cancer Radiother, 17, 419-23.
-
(2013)
Cancer Radiother
, vol.17
, pp. 419-423
-
-
Truc, G.1
Martin, E.2
Mirjolet, C.3
-
17
-
-
84884815066
-
Poor Outcomes after Whole Brain Radiotherapy in Patients with Brain Metastases: Results from an International Multicentre Cohort Study
-
Windsor AA, Koh ES, Allen S, et al (2013). Poor Outcomes after Whole Brain Radiotherapy in Patients with Brain Metastases: Results from an International Multicentre Cohort Study. Clin Oncol (R Coll Radiol), 25, 674-680.
-
(2013)
Clin Oncol (R Coll Radiol)
, vol.25
, pp. 674-680
-
-
Windsor, A.A.1
Koh, E.S.2
Allen, S.3
-
18
-
-
84875720245
-
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer
-
Welsh JW, Komaki R, Amini A, et al (2013). Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol, 31, 895-902.
-
(2013)
J Clin Oncol
, vol.31
, pp. 895-902
-
-
Welsh, J.W.1
Komaki, R.2
Amini, A.3
-
19
-
-
85008416722
-
Preliminary results of Erlotinib concomitant with radiation therapy for non-small cell lung cancer patients with multiple brain metastasis
-
Zhang XP, Li JK, Huang LJ, et al (2007). Preliminary results of Erlotinib concomitant with radiation therapy for non-small cell lung cancer patients with multiple brain metastasis. Chin J Neuro Oncol, 5, 180-2.
-
(2007)
Chin J Neuro Oncol
, vol.5
, pp. 180-182
-
-
Zhang, X.P.1
Li, J.K.2
Huang, L.J.3
|